News, Commentary & Events: MSOS

ADVISORSHARES PURE US CANNABIS ETF

6.96up0.00 (0.00%)

 as of 4:10:00pm ET 02/06/2023
  • Show article details.

    What Makes Upside Potential For Hexo? Analyst Explains On Heels Of The Deal Break With Molson Coors

    Benzinga - 12/01/2022

    Year-to-date, Hexo  shares lost 77.15%, compared to AdvisorShares Pure Cannabis ETF which went down 61.12%, and AdvisorShares Pure US Cannabis ETF , which dropped 53.70%. Recently, the multinational drink and brewing company Molson Coors said goodbye to cannabis and its partnership with Hexo.

  • Show article details.

    Election Results And Marijuana: What Happened With Weed In Arkansas, Maryland, Missouri, North Dakota & South Dakota?

    Benzinga - 11/09/2022

    On Tuesday, citizens in five states voted on whether or not to legalize cannabis for adult use. In addition to these five states, Ohio, Texas and Wisconsin voted on local cannabis ballot questions and Colorado voted on whether or not to legalize psychedelics. Below is a look at how each of the five states voting on weed decided.

  • Show article details.

    Mostly Tricks, Few Treats For Pot Stocks in 2022

    Benzinga - 10/30/2022

    Halloween is prime spooky season, but for most investors, all of 2022 has been quite scary. Cannabis' surging pandemic performances have been dashed mostly. Halloween is just the latest reminder of what is terrifying in cannabis investing. 2022 has been a down year across much of the board, including most MSOs, ETFs and ancillary brands.

  • Show article details.

    Here's What Needs To Happen Next For Marijuana Stocks To Be Uplisted On Major US Exchanges

    Benzinga - 10/13/2022

    President Biden's recent announcement regarding marijuana pardons was a historic step toward cannabis legalization on the federal level. Biden in fact said he would ask the Attorney General and Department of Health and Human Services to review marijuana's classification under federal law as a Schedule I drug, which happens to be the same as heroin and LSD.

  • Show article details.

    Why This Cannabis ETF Surged 34% Today

    Benzinga - 10/06/2022

    Shares of the AdvisorShares Trust AdvisorShares Pure US Cannabis ETF  closed 34% higher in Thursday's session after President Joe Biden issued a statement on marijuana reform that includes a pardon of all prior federal offenses of simple marijuana possession. Biden also called on governors to "pardon simple state marijuana possession offenses."

  • Show article details.

    AdvisorShares Expands Cannabis ETF Offerings, Launches MSOS 2X Daily ETF MSOX

    Benzinga - 08/24/2022

    AdvisorShares revealed that the AdvisorShares MSOS 2x Daily ETF will begin trading on August 24th. MSOX seeks daily investment results that, before fees and expenses, correspond to two times the daily total return of the AdvisorShares Pure US Cannabis ETF . MSOX does not seek to achieve its stated investment objective over a period of time greater than a single day.

  • Show article details.

    These Are The Most Important Investors In The Cannabis Industry

    Benzinga - 08/23/2022

    Despite regulatory hurdles, the experienced and engaged cannabis investors nominated for this year's Benzinga's Cannabis Investors Award are making it possible for everyone to tap into the market's potential. After the overwhelming success of Benzinga's 4/20 Miami event, the Benzinga Cannabis Capital Conference is returning to Chicago on September 13-14.

  • Show article details.

    What Are The Best-Performing Marijuana Stocks? These Investors Will Tell All At Benzinga's Cannabis Capital Conference

    Benzinga - 08/19/2022

    Despite regulatory hurdles, the experienced and engaged cannabis investors nominated for this year's Benzinga's Cannabis Investors Award are making it possible for everyone to tap into the market's potential. After the overwhelming success of Benzinga's 4/20 Miami event, the Benzinga Cannabis Capital Conference is returning to Chicago on September 13-14.

  • Show article details.

    Sun, Water, Weed And B2B?: What Opportunities Can Cannabis Investors Expect From This Conference In Panama

    Benzinga - 08/15/2022

    By Franca Quarneti via El Planteo. The cannabis industry is advancing quickly in Panama, a country located on the isthmus between Central and South America. "Panama has enormous competitive advantages and can quickly become an import and export hub for the entire world. Likewise, the expert outlined the enormous potential of the industry to boost employment and economic growth.

  • Show article details.

    Projected Benefits For TerrAscend Overestimated, Says Cantor & Downgrades Cannabis Stock To 'Neutral'

    Benzinga - 08/12/2022

    TerrAscend Corp.  reported its financial results on Thursday for the second quarter ending June 30, with net sales of $65 million, compared to $50 million in the previous quarter. Gross Profit Margin was 35.5% as compared to 30.4% in Q1 2022. Adjusted EBITDA was $5.8 million as compared to $3.3 million in Q1 2022.

More News:

Commentary

  • Best & Worst Monthly Performers: February 1 Edition

    ETF Database - 02/01/2023

    Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as potential starting points for those looking to take on either short or long positions. Likewise, traders can also use this list to spot potential trend reversal opportunities that may offer a generous risk/reward. As always, investors of all experience levels are advised to use stop-loss orders and practice disciplined profit-taking techniques. To get access to all ETF Database premium content, sign up for a free 14-day trial to ETF Database Pro.

  • Best & Worst Monthly Performers: January 4 Edition

    ETF Database - 01/04/2023

    Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as potential starting points for those looking to take on either short or long positions. Likewise, traders can also use this list to spot potential trend reversal opportunities that may offer a generous risk/reward. As always, investors of all experience levels are advised to use stop-loss orders and practice disciplined profit-taking techniques. To get access to all ETF Database premium content, sign up for a free 14-day trial to ETF Database Pro.

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. The sale of ETFs is subject to an activity assessment fee (from $0.01 to $0.03 per $1,000 of principal). ETFs are subject to market fluctuation and the risks of their underlying investments. ETFs are subject to management fees and other expenses. Unlike mutual funds, ETF shares are bought and sold at market price, which may be higher or lower than their NAV, and are not individually redeemed from the fund.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF’s prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock Inc., and its affiliates.

Fidelity receives compensation from the funds advisor or its affiliates in connection with a licensing agreement to utilize Fidelity’s active ETF methodology which may create incentives for FBS to encourage the purchase of certain ETFs.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

© 2010 Morningstar, Inc. All rights reserved. The Morningstar information contained herein (1) is proprietary to Morningstar or its affiliates; (2) may not be copied or redistributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.

462499.7.0